Search results
Order by most recent / most popular / relevance
Results: 11-20 of 27
China further revises rules for foreign investment in pharmaceutical industry
- Sidley Austin LLP
- -
- China
- -
- January 3 2012
On December 24, 2011, China’s National Development & Reform Commission published the amended Industry Catalogue for Foreign Investments
China issues rules on drug pricing investigation
- Sidley Austin LLP
- -
- China
- -
- November 28 2011
On November 9, 2011, China’s National Development and Reform Commission (NDRC) released a regulation entitled Trial Measures for Investigation on Ex-Factory Prices of Drugs, which will enter into effect on December 1, 2011
SFDA releases proposed revisions to China drug distribution regulations
- Sidley Austin LLP
- -
- USA
- -
- November 4 2011
On October 14, 2011, the State Food and Drug Administration (SFDA) released another round of proposed revisions to the Administrative Measures for Drug Distribution License (Draft Measures) for public comment by November 30, 2011
SDFA clarifies requirements for Foreign Pre-Clinical Data
- Sidley Austin LLP
- -
- China
- -
- November 3 2011
As more and more local drug applicants use pharmacological and toxicological data generated from foreign pre-clinical studies (the Foreign Pre-Clinical Data) to support their regulatory filings in China, SFDA recently stated that it will require local applicants to provide additional, notarized and legalized supporting documents to prove the reliability of the Foreign Pre-Clinical Data
SFDA regulates drug administration in medical institutions
- Sidley Austin LLP
- -
- China
- -
- November 2 2011
In order to regulate the safe use of drugs by medical institutions, SFDA promulgated Measures on Drug Supervision and Administration in Medical Institutions (Trial Implementation) (the Measures) on October 11, 2011
China promulgates device safety monitoring guidance
- Sidley Austin LLP
- -
- China
- -
- September 27 2011
On September 16, 2011, the State Administration of Food and Drug (SFDA) unveiled the Tentative Guidance for the Monitoring of Adverse Device Events (Guidance
China SFDA imposes new regulatory requirements on cross-border pharmaceutical contract manufacturing activities
- Sidley Austin LLP
- -
- China
- -
- August 15 2011
On July 22, 2011, the China State Food and Drug Administration (“SFDA”) published a notice on strengthening its supervision over domestic contract manufacturing activities for foreign pharmaceutical manufacturers (the “Notice”), with an aim to prevent export counterfeiting
China strengthening controls over human genetic resources
- Sidley Austin LLP
- -
- China
- -
- June 21 2011
The Ministry of Science and Technology (“MOST”), the Ministry of Health (“MOH”) and the National Population and Family Planning Commission (“MPFPC”) of the Peoples Republic of China jointly issued a Notice Concerning the Protection and Administration of Human Genetic Resources (“HGR Notice”) on June 2, 2011
Chinese CDE launches joint review for chemical drug and API applications and other life sciences regulatory updates
- Sidley Austin LLP
- -
- China
- -
- June 16 2011
The Center for Drug Evaluation (CDE) of the Chinese State Food and Drug Administration (SFDA) released a notice on June 7, 2011, establishing joint review for applications for chemical drugs and their active pharmaceutical ingredients (APIs) with a view to improving drug approval efficiency
China unveils draft regulations on labeling requirements for health foods
- Sidley Austin LLP
- -
- China
- -
- June 7 2011
The State Food and Drug Administration ("SFDA") recently published an updated draft of the Rules on the Administration of Product Insert Sheets and Labels of Health Foods ("Draft Labeling Rules") for public comments
Current Search
- Firm Name - Sidley Austin LLP
- Author - Zhengyu Tang
- Author - Katherine Wang